Xiao Qiang - Net Worth and Insider Trading

Xiao Qiang Net Worth

The estimated net worth of Xiao Qiang is at least $2 Million dollars as of 2024-06-22. Xiao Qiang is the senior management of Harbin Pharmaceutical Group Co Ltd and owns about 650,000 shares of Harbin Pharmaceutical Group Co Ltd (SHSE:600664) stock worth over $2 Million. Details can be seen in Xiao Qiang's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Xiao Qiang has not made any transactions after 2021-05-12 and currently still holds the listed stock(s).

Transaction Summary of Xiao Qiang

To

Xiao Qiang Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Xiao Qiang owns 1 companies in total, including Harbin Pharmaceutical Group Co Ltd (SHSE:600664) .

Click here to see the complete history of Xiao Qiang’s form 4 insider trades.

Insider Ownership Summary of Xiao Qiang

Ticker Comapny Transaction Date Type of Owner
SHSE:600664 Harbin Pharmaceutical Group Co Ltd 2021-05-12 senior management

Xiao Qiang Latest Holdings Summary

Xiao Qiang currently owns a total of 1 stock. Xiao Qiang owns 650,000 shares of Harbin Pharmaceutical Group Co Ltd (SHSE:600664) as of May 12, 2021, with a value of $2 Million.

Latest Holdings of Xiao Qiang

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SHSE:600664 Harbin Pharmaceutical Group Co Ltd 2021-05-12 650,000 2.73 1,774,500

Holding Weightings of Xiao Qiang


Xiao Qiang Form 4 Trading Tracker

According to the SEC Form 4 filings, Xiao Qiang has made a total of 1 transactions in Harbin Pharmaceutical Group Co Ltd (SHSE:600664) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Harbin Pharmaceutical Group Co Ltd is the sale of 650,000 shares on May 12, 2021, which brought Xiao Qiang around $884,000.

Insider Trading History of Xiao Qiang

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Xiao Qiang Trading Performance

GuruFocus tracks the stock performance after each of Xiao Qiang's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Xiao Qiang is 4.61%. GuruFocus also compares Xiao Qiang's trading performance to market benchmark return within the same time period. The performance of stocks bought by Xiao Qiang within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Xiao Qiang's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Xiao Qiang

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -6.25 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -10.79 LIMIT LIMIT LIMIT LIMIT LIMIT

Xiao Qiang Ownership Network

Ownership Network List of Xiao Qiang

No Data

Ownership Network Relation of Xiao Qiang

Insider Network Chart

Xiao Qiang Owned Company Details

What does Harbin Pharmaceutical Group Co Ltd do?

Who are the key executives at Harbin Pharmaceutical Group Co Ltd?

Xiao Qiang is the senior management of Harbin Pharmaceutical Group Co Ltd. Other key executives at Harbin Pharmaceutical Group Co Ltd include senior management Lin Guo Ren , senior management Wang Hai Sheng , and senior management Liu Bo .

Harbin Pharmaceutical Group Co Ltd (SHSE:600664) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Harbin Pharmaceutical Group Co Ltd (SHSE:600664) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Harbin Pharmaceutical Group Co Ltd (SHSE:600664) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Harbin Pharmaceutical Group Co Ltd (SHSE:600664)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Harbin Pharmaceutical Group Co Ltd Insider Transactions

No Available Data

Xiao Qiang Mailing Address

Above is the net worth, insider trading, and ownership report for Xiao Qiang. Currently GuruFocus does not have mailing address information for Xiao Qiang.

Discussions on Xiao Qiang

No discussions yet.